GLPBio

Poly-L-lysine hydrobromide (MW 150000-300000)

Catalog No.: GC19602

Poly-L-lysine hydrobromide (MW 150000-300000) is a high-molecular-weight, positively charged synthetic polypeptide widely used to enhance cell adhesion to culture surfaces. Poly-L-lysine hydrobromide exhibits excellent water solubility and biocompatibility and serves as an essential reagent for the culture of primary neurons, epithelial cells, and stem cells.

المنتجات مخصصة للاستخدام البحثي فقط، وليست للاستخدام البشري. نحن لا نبيع للمرضى.


Poly-L-lysine hydrobromide (MW 150000-300000)
Cas No.: 25988-63-0
25mgIn Stock
$240.00
1
100mgIn Stock
$720.00
1
250mgIn Stock
$1,440.00
1

المراجع (Citations)

لا تتوفر حاليًا مراجع لهذا المنتج. فيما يلي مجموعة مختارة من المنشورات التي تستشهد بمنتجات GlpBio.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

الوصف (Description)

Poly-L-lysine hydrobromide (MW 150000-300000) is a high-molecular-weight, positively charged synthetic polypeptide widely used to enhance cell adhesion to culture surfaces. Poly-L-lysine hydrobromide exhibits excellent water solubility and biocompatibility and serves as an essential reagent for the culture of primary neurons, epithelial cells, and stem cells[1-2]. When coated onto substrates, Poly-L-lysine hydrobromide forms a stable, uniform layer that resists detachment during long-term culture[3], and Poly-L-lysine hydrobromide is also employed as a drug-delivery vehicle[4].

In vitro, Poly-L-lysine hydrobromide (20μg/mL) applied to HeLa cells for 30min–2h significantly inhibits tumor-cell DNA, RNA, and protein synthesis, alters membrane permeability, induces leakage of intracellular small molecules, and causes cell rounding, granulation, and lysis[5]. Treatment of Jurkat T-cells, THLE-3 hepatocyte-like cells, and human umbilical vein endothelial cells (HUVEC) with Poly-L-lysine hydrobromide(10–30μg/ml) for 24h markedly induces apoptosis, as evidenced by mitochondrial membrane potential loss, cytochrome c release, and activation of caspase-9 and caspase-3.[6].

In vivo, Poly-L-lysine hydrobromide (50mg/kg/day; i.v.) administered to C57BL/6 mice bearing subcutaneous B16F10 melanoma on days 1 and 2 post-inoculation markedly suppresses tumor neovascularization, induces widespread tumor-cell apoptosis/necrosis, and delays solid-tumor growth[7]. A single intraluminal insertion of a 5-0 monofilament nylon suture coated with 0.1%w/v Poly-L-lysine hydrobromide into the internal carotid artery of C57BL/6 mice produces 30–180min middle-cerebral-artery occlusion followed by 24h reperfusion, resulting in 100% consistent infarcts in expected ipsilateral regions (striatum, thalamus, hippocampus, frontoparietal cortex) and time-dependent neurological deficits[8].

References:
[1] Olivera-Ardid S, Bello-Gil D, Tuzikov A et al, et al. Poly-L-Lysine-Based αGal-Glycoconjugates for Treating Anti-αGal IgE-Mediated Diseases. Front Immunol. 2022 Mar 31;13:873019.
[2] Hatcher JM, Zwirek M, Sarhan AR, et al. Development of a highly potent and selective degrader of LRRK2. Bioorg Med Chem Lett. 2023 Oct 1;94:129449.
[3] Tengberg JF, Russo F, Benned-Jensen T, et al. LRRK2 and RAB8A regulate cell death after lysosomal damage in macrophages through cholesterol-related pathways. Neurobiol Dis. 2024 Nov;202:106728.
[4] Harsiddharay RK, Gupta A, Singh PK, et al. Poly-L-lysine Coated Oral Nanoemulsion for Combined Delivery of Insulin and C-Peptide. J Pharm Sci. 2022 Dec;111(12):3352-3361.
[5] Arnold LJ Jr, Dagan A, Gutheil J, et al. Antineoplastic activity of poly(L-lysine) with some ascites tumor cells. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3246-50.
[6] Symonds P, Murray JC, Hunter AC, et al. Low and high molecular weight poly(L-lysine)s/poly(L-lysine)-DNA complexes initiate mitochondrial-mediated apoptosis differently. FEBS Lett. 2005 Nov 7;579(27):6191-8.
[7] Al-Jamal KT, Al-Jamal WT, Akerman S, et al. Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth. Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):3966-71.
[8] Belayev L, Busto R, Zhao W, et al. Middle cerebral artery occlusion in the mouse by intraluminal suture coated with poly-L-lysine: neurological and histological validation. Brain Res. 1999 Jul 3;833(2):181-90.

Experimental Protocol:
1. Prepare a 1mg/mL poly-lysine stock solution in sterile water, sterilize by filtration through a 0.22μm microporous filter, and store in aliquots at -20°C.
2. Dilute to 0.1mg/mL with sterile ultrapure water before use.
Note: It is recommended to use plastic containers and graduated cylinders when mixing or storing the solution and coating slides. Do not add fresh solution to used solution.
3. Equilibrate the diluted poly-lysine working solution to room temperature (18–26°C) before use.
4. Add the poly-lysine working solution to the culture vessel, gently rock to ensure even coverage, and incubate at room temperature for 5–10 minutes.
5. Aspirate the working solution, wash the culture vessel 1–2 times with PBS, and dry in an oven at 60°C for 1 hour or at room temperature (18–26°C) overnight.
Note: Poly-lysine is cytotoxic; the concentration of the coating solution may be reduced depending on specific experimental requirements.

البروتوكول (Protocol)

Cell experiment [1]:

Cell lines

Jurkat T-cells, THLE-3 hepatocyte-like cells, and human umbilical vein endothelial cells (HUVEC)

Preparation Method

Cells were seeded into 12- or 24-well plates at 1×10⁶ cells/ml and cultured in serum-free RPMI-1640. After 24h, fresh medium containing Poly-L-lysine hydrobromide (PLL) or PLL–DNA complexes was added.

Reaction Conditions

10–30μg/ml; 24h.

Applications

Poly-L-lysine hydrobromide induced significant apoptosis, manifested by mitochondrial membrane potential loss, cytochrome c release, and activation of caspases-9 and -3.
Animal experiment [2]:

Animal models

C57BL/6 mice (B16F10 melanoma) and SCID mice (P22 rat sarcoma).

Preparation Method

Subcutaneous implantation of 1 × 10⁶ B16F10 cells or dorsal window-chamber implantation of P22 fragments; 24h later, mice received the first of two daily tail-vein administrations of Poly-L-lysine hydrobromide (50mg/kg) or PBS, followed by tissue harvest on day 10.

Dosage form

50mg/kg/day; i.v.

Applications

Poly-L-lysine hydrobromide dendrimer significantly suppressed intratumoral vascularization, induced extensive tumor-cell apoptosis/necrosis, and delayed solid-tumor growth without systemic toxicity.

References:
[1] Mukherjee A, Debnath S, Bhowmik A, et al. DNA interactive property of poly-L-lysine induces apoptosis in MCF-7 cells through DNA interaction. J Biochem Mol Toxicol. 2023 Aug;37(8):e23378.
[2] Al-Jamal KT, Al-Jamal WT, Akerman S, et al. Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth. Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):3966-71.

وثائق المنتج (Product Documents)

Appearance:A solid

الخصائص الكيميائية (Chemical Properties)

رقم CAS
25988-63-0
SMILES
CN[C@@H](CCCC[NH3+])C(C)=O.[n].[Br-].[n]
الصيغة الجزيئية
C8H19BrN2O
الوزن الجزيئي
150000-300000
الذوبانية
H2O : 25 mg/mL (Need ultrasonic)
التخزين
4°C, sealed storage, away from moisture and light
إرشادات عامة
اختر مذيبًا مناسبًا وفقًا لبيانات ذوبانية المنتج. بعد التحضير، قسّم المحلول المخزون إلى أجزاء لتجنب دورات التجميد والذوبان المتكررة.
استخدم المحاليل المخزونة خلال 6 أشهر عند حفظها في -80°C، أو خلال شهر واحد عند حفظها في -20°C.
لتحسين الذوبانية، سخّن الأنبوب إلى 37°C وعرّضه للموجات فوق الصوتية لمدة مناسبة.
شروط الشحن
تُشحن عينات التقييم مع عبوات تبريد. وتُشحن الأحجام الأخرى المتاحة في درجة حرارة الغرفة، أو مع عبوات تبريد عند الطلب.

الحاسبات (Calculators)المولارية / التخفيف / الوزن الجزيئي / تحويل الوحدات / تركيبة داخل الجسم الحي / الذوبانية

g/mol

Reviews

Review for Poly-L-lysine hydrobromide (MW 150000-300000)

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%